Autologous stem cell transplant (ASCT) remains an important option for eligible multiple myeloma (MM) pat...
Read moreWe are pleased to let you know that as of September 1st, selinexor – under the following conditions – is...
Read moreB cell maturation antigen (BCMA) target loss is considered to be a rare event that mediates multiple myel...
Read moreOn the recommendation of Dean Jane Philpott, Teri Shearer, Interim Provost and Vice-Principal (Academic)...
Read moreNew vaccine formulations targeting currently circulating strains are expected. The country's national vac...
Read moreThrough Bill C-224, starting next year, the month of January will be declared “Firefighter Cancer Awarene...
Read moreJoin our community and sign up for our newsletter.
